BTNX Rapid Response COVID-19 Antigen Test (5 Pack)


Purchasing Options: 1 Box - 5

Quantity Limit Reached

  • Expiry 01/01/2024. Later expiry available - Please email

    The BTNX Rapid Response COVID-19 Antigen Test is authorized for use by Health Canada (Interim Authorization Number: 321669). Before Rapid Testing kits can be purchased, the following training materials and documents must be reviewed:

    BTNX COVID-19 Antigen Rapid Testing Device Instructional Video

    BTNX Rapid Response Product Manual

    BTNX Rapid Response Procedure Card

    It is your responsibility to ensure that you have the appropriate knowledge, skills and judgement to perform the test.

    Rapid antigen testing devices should only be used for screening purposes. Nucleic acid-based testing, also called molecular testing or PCR, is the gold standard to diagnose active COVID-19 infection in patients with symptoms. For more information about self-testing and antigen testing devices, please visit the Health Canada website here.

    ** All Rapid Tests are FINAL SALE – we cannot offer cancellations or refunds after your order has been placed. ** 

  • The Rapid Response™ COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions.

    In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test. 

    Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but other diagnostic information is necessary to determine infection status.

    Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.

    The Rapid Response COVID-19 Antigen Rapid Test Device, manufactured by BTNX Inc., is a Health Canada authorized COVID-19 testing device.

    Accessible, large-scale testing helps contain the virus spread.  It is the perfect screening tool for organizations that want to protect their workplace from the risk of COVID-19 transmission.

    • Test time: 15 minutes
    • Test Technology: Antigen 
    • Diagnostic Sensitivity: 78.6% - 96.2%
    • Diagnostic Specificity 96.5%-100%
    • Quantity: 5 tests/kit
    • Sample Collection: Shallow nasal
    • Each Rapid Test Kit Contains: 5 x Test cassettes, 5 x Individually packed swabs, 5 x individually packed buffers, 5 x tubes and nozzles, 1 x Tube stand, 1 x Product insert
    • Pricing is listed per test 
    • Expiry 01/01/2024. Later expiry available - Please email

    **5-PACK DOES NOT CONTAIN BOTTLE OF BUFFER LIQUID (it includes 5 x individual buffer liquid packs)**

  • Easily deployed at a large scale

    Can be used in a wide variety of non-laboratory settings

    No special/additional instruments required

    Self-contained tube with "break off" swab minimizes staff exposure

    Extraction tube is fully enclosed for disposal 


    Information, regulations, and guidance around the use of rapid antigen testing devices in Canada is frequently changing. While The Safe Direct website is updated often, we recommend referring to the Health Canada website for the most up to date information on:

    Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection

    Overview of Testing Devices for COVID-19

    Antigen Testing Devices

    Point-of-care and self-testing devices

    Test Swabs

    List of Authorized Testing Devices

You may also like